This event took place on October 3, 2020
Neurologists, internal medicine, and family medicine physicians, physician assistants, nurse practitioners, and others who treat or manage patients with headache disorders.
After the symposium, participants should be able to:
- Recognize uncommon headache syndrome and their respective treatment
- Improve approach and treatment of facial pain and sinus headache
- Improve our understanding of sleep disorder
- Learn about available behavioral approaches to headache disorders
- Summarize new advances in headache therapy
7:50 – 8 a.m. Welcome & Opening Remarks
8 – 8:45 Uncommon headache syndrome: diagnosis and treatment
Emily Riddle, M.D., Headache Medicine, OHSU Neurology
8:45 – 9:30 Approach to headache management during COVID pandemic
Juliette Preston, M.D., Headache Medicine, OHSU Neurology
9:30 – 10:15 Sleep disorders: approach and treatment
Asha Singh, M.D., Sleep Medicine, OHSU Neurology
10:15 – 10:30 Break
10:30 – 11:15 Behavioral approaches to headache disorders
Daniel Krashin, M.D., Psychiatry, Veteran Affairs, Washington
11:15 – 12:15 New and emerging therapies in Headache Medicine
Natalia Murinova, M.D., Headache Medicine, University of Washington
12:15 – 12:30 Closing Remarks
Thank you to our Premium Exhibitors
- Allergan an AbbVie Company
- Teva Pharmaceuticals
- Upsher-Smith Laboratories, LLC
Accreditation: The School of Medicine, Oregon Health & Science University (OHSU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: Oregon Health & Science University School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Providers should claim only the credit commensurate with the extent of their participation in the activity.
Please contact Dina Girgenti-Iida (971 244-2189)with questions.